JC Hobart

3.1k total citations · 1 hit paper
28 papers, 2.2k citations indexed

About

JC Hobart is a scholar working on Pathology and Forensic Medicine, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, JC Hobart has authored 28 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 6 papers in Psychiatry and Mental health and 5 papers in Cognitive Neuroscience. Recurrent topics in JC Hobart's work include Multiple Sclerosis Research Studies (13 papers), Cerebral Palsy and Movement Disorders (5 papers) and Stroke Rehabilitation and Recovery (4 papers). JC Hobart is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Cerebral Palsy and Movement Disorders (5 papers) and Stroke Rehabilitation and Recovery (4 papers). JC Hobart collaborates with scholars based in United Kingdom, United States and Australia. JC Hobart's co-authors include Alan J. Thompson, Jennifer Freeman, SJ Cano, JP Zajicek, Stefan Cano, Camille Carroll, Timothy Hsu, Holly Posner, Jina Swartz and Stephen W. Hurt and has published in prestigious journals such as Brain, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

JC Hobart

26 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure

2001 865 citations JC Hobart Brain profile →

Peers

Countries citing papers authored by JC Hobart

Since Specialization

Citations

This map shows the geographic impact of JC Hobart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JC Hobart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JC Hobart more than expected).

Fields of papers citing papers by JC Hobart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JC Hobart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JC Hobart. The network helps show where JC Hobart may publish in the future.

Co-authorship network of co-authors of JC Hobart

This figure shows the co-authorship network connecting the top 25 collaborators of JC Hobart. A scholar is included among the top collaborators of JC Hobart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JC Hobart. JC Hobart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimal strategies for treatment discontinuation in MOG antibody-associated disease 2026 ·Brain ·Wei Zhen Yeh, (unknown), (unknown), Waqar Rashid, (unknown), JC Hobart, Christopher Halfpenny, (unknown), (unknown), (unknown), (unknown), (unknown), Patrick Waters, Srilakshmi M. Sharma, (unknown), (unknown), (unknown), Maria Isabel Leite, (unknown)	0
2	Dimensionality is a relative concept 2011 ·Multiple Sclerosis Journal ·SJ Cano, (unknown), JP Zajicek, JC Hobart	9
3	The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts 2010 ·Journal of Neurology Neurosurgery & Psychiatry ·Stefan Cano, Holly Posner, Margaret Moline, Stephen W. Hurt, Jina Swartz, Timothy Hsu, JC Hobart	143
4	Effect sizes can be misleading: is it time to change the way we measure change? 2010 ·Journal of Neurology Neurosurgery & Psychiatry ·JC Hobart, SJ Cano, Alan J. Thompson	45
5	Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations (vol 6, pg 1094, 2007) 2008 ·UCL Discovery (University College London) ·JC Hobart, SJ Cano, JP Zajicek, Alan J. Thompson	0
6	Getting the measure of spasticity in MS: The Multiple Sclerosis Spasticity Scale (MSSS-88) 2006 ·UCL Discovery (University College London) ·JC Hobart, Afsane Riazi, Alan J. Thompson, (unknown), Wendy Ingram, (unknown), Martin Warner, (unknown), JP Zajicek	1
7	International co-operative ataxia rating scale (ICARS): Suitable for clinical practice and treatment trials in Friedreich's ataxia? 2006 ·Journal of Neurology Neurosurgery & Psychiatry ·SJ Cano, JC Hobart, (unknown), (unknown), Anthony H.V. Schapira, Jonathan M. Cooper	1
8	Getting the measure of spasticity in MS: the multiple sclerosis spasticity scale 2005 ·UCL Discovery (University College London) ·JC Hobart, Afsane Riazi, Alan J. Thompson, Irene Styles, Wendy Ingram, Jane Vickery, Martin Warner, Patrick J. Fox, John Zajicek	1
9	Measuring quality of life in multiple sclerosis: not as simple as it sounds 2005 ·Multiple Sclerosis Journal ·(unknown), JC Hobart, Fiona Cramp, (unknown)	21
10	Disability assessment in multiple sclerosis 2004 ·UWE Research Repository (UWE Bristol) ·(unknown), JC Hobart, Lynn Dunwoody, Fiona Cramp, A Lowe-Strong	1
11	Developing a measure of patients' experiences of relapse management in multiple sclerosis. 2003 ·UCL Discovery (University College London) ·Afsane Riazi, JC Hobart, Bernadette Porter, Jeremy Chataway, Alan J. Thompson	1
12	The SF-36 in multiple sclerosis: why basic assumptions must be tested 2001 ·Journal of Neurology Neurosurgery & Psychiatry ·JC Hobart	113
13	The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure breakdown → 2001 ·Brain ·JC Hobart	865
14	The five item Barthel index 2001 ·Journal of Neurology Neurosurgery & Psychiatry ·JC Hobart	107
15	Kurtzke scales revisited: the application of psychometric methods to clinical intuition 2000 ·Brain ·JC Hobart	245
16	Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel Index and the Functional Independence Measure 1999 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), JC Hobart, Jennifer Freeman, Alan J. Thompson	294
17	The Impact of In-patient Rehabilitation on Disability and Handicap in Progressive Multiple Sclerosis: A randomised controlled trial 1998 ·Physiotherapy* ·(unknown), Dawn Langdon, JC Hobart, Alan J. Thompson	2
18	Outcomes-based research in neurorehabilitation: The need for multidisciplinary team involvement 1996 ·Disability and Rehabilitation ·Jenny Freeman, JC Hobart, Alan J. Thompson	9
19	Reduced Disability Following Rehabilitation in Patients with Progressive Multiple Sclerosis 1995 ·Physiotherapy ·(unknown), Dawn Langdon, JC Hobart, Alan J. Thompson	1
20	Immediate and long term effects of inpatient rehabilitation in progressive multiple sclerosis (MS): Initial report 1995 ·Journal of Neuroimmunology ·(unknown), JC Hobart, Dawn Langdon, Alan J. Thompson	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact